These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 29768630)
21. Use of fusion images of I-131 metaiodobenzylguanidine, SPECT, and magnetic resonance studies to identify a malignant pheochromocytoma. Fujita A; Hyodoh H; Kawamura Y; Kanegae K; Furuse M; Kanazawa K Clin Nucl Med; 2000 Jun; 25(6):440-2. PubMed ID: 10836692 [TBL] [Abstract][Full Text] [Related]
22. Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review. Casey RT; Warren AY; Martin JE; Challis BG; Rattenberry E; Whitworth J; Andrews KA; Roberts T; Clark GR; West H; Smith PS; Docquier FM; Rodger F; Murray V; Simpson HL; Wallis Y; Giger O; Tran M; Tomkins S; Stewart GD; Park SM; Woodward ER; Maher ER J Clin Endocrinol Metab; 2017 Nov; 102(11):4013-4022. PubMed ID: 28973655 [TBL] [Abstract][Full Text] [Related]
23. Genotype-phenotype correlation in paediatric pheochromocytoma and paraganglioma: a single centre experience from India. Khadilkar K; Sarathi V; Kasaliwal R; Pandit R; Goroshi M; Shivane V; Lila A; Bandgar T; Shah NS J Pediatr Endocrinol Metab; 2017 May; 30(5):575-581. PubMed ID: 28432847 [TBL] [Abstract][Full Text] [Related]
24. Familial nonsyndromic pheochromocytoma. Opocher G; Schiavi F; Iacobone M; Toniato A; Sattarova S; Erlic Z; Martella M; Mian C; Merante Boschin I; Zambonin L; De Lazzari P; Murgia A; Pelizzo MR; Favia G; Mantero F Ann N Y Acad Sci; 2006 Aug; 1073():149-55. PubMed ID: 17102081 [TBL] [Abstract][Full Text] [Related]
25. Mutations seen among patients with pheochromocytoma and paraganglioma at a referral center from India. Pai R; Ebenazer A; Paul MJ; Thomas N; Nair A; Seshadri MS; Oommen R; Shanthly N; Devasia A; Rebekah G; Jeyaseelan L; Rajaratnam S Horm Metab Res; 2015 Feb; 47(2):133-7. PubMed ID: 24977658 [TBL] [Abstract][Full Text] [Related]
26. Role of miR-101 in pheochromocytoma patients with SDHD mutation. Zong L; Meng L; Shi R Int J Clin Exp Pathol; 2015; 8(2):1545-54. PubMed ID: 25973039 [TBL] [Abstract][Full Text] [Related]
27. Denaturing high performance liquid chromatography detection of SDHB, SDHD, and VHL germline mutations in pheochromocytoma. Meyer-Rochow GY; Smith JM; Richardson AL; Marsh DJ; Sidhu SB; Robinson BG; Benn DE J Surg Res; 2009 Nov; 157(1):55-62. PubMed ID: 19215943 [TBL] [Abstract][Full Text] [Related]
34. A case of (123)I-MIBG scintigram-negative functioning pheochromocytoma: immunohistochemical and molecular analysis with review of literature. Kurisaki-Arakawa A; Saito T; Takahashi M; Mitani K; Yao T Int J Clin Exp Pathol; 2014; 7(7):4438-47. PubMed ID: 25120831 [TBL] [Abstract][Full Text] [Related]
35. Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma. Buffet A; Ben Aim L; Leboulleux S; Drui D; Vezzosi D; Libé R; Ajzenberg C; Bernardeschi D; Cariou B; Chabolle F; Chabre O; Darrouzet V; Delemer B; Desailloud R; Goichot B; Esvant A; Offredo L; Herman P; Laboureau S; Lefebvre H; Pierre P; Raingeard I; Reznik Y; Sadoul JL; Hadoux J; Tabarin A; Tauveron I; Zenaty D; Favier J; Bertherat J; Baudin E; Amar L; Gimenez-Roqueplo AP; J Clin Endocrinol Metab; 2019 Apr; 104(4):1109-1118. PubMed ID: 30698717 [TBL] [Abstract][Full Text] [Related]
36. Prognostic Factors of Malignant Pheochromocytoma and Paraganglioma: A Combined SEER and TCGA Databases Review. Mei L; Khurana A; Al-Juhaishi T; Faber A; Celi F; Smith S; Boikos S Horm Metab Res; 2019 Jul; 51(7):451-457. PubMed ID: 30919391 [TBL] [Abstract][Full Text] [Related]
37. Multiple endocrine neoplasia type 2 with malignant pheochromocytoma--long term follow-up of a case by 131I-meta-iodobenzylguanidine scintigraphy. Namba H; Kondo H; Yamashita S; Kimura H; Yokoyama N; Tsuruta M; Sato A; Izumi M; Kinoshita H; Hakariya S Ann Nucl Med; 1992 May; 6(2):111-5. PubMed ID: 1352456 [TBL] [Abstract][Full Text] [Related]
38. [131I]metaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication. Hoefnagel CA; Schornagel J; Valdés Olmos RA J Nucl Biol Med (1991); 1991; 35(4):308-12. PubMed ID: 1823843 [TBL] [Abstract][Full Text] [Related]
39. Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients. Erlic Z; Rybicki L; Peczkowska M; Golcher H; Kann PH; Brauckhoff M; Müssig K; Muresan M; Schäffler A; Reisch N; Schott M; Fassnacht M; Opocher G; Klose S; Fottner C; Forrer F; Plöckinger U; Petersenn S; Zabolotny D; Kollukch O; Yaremchuk S; Januszewicz A; Walz MK; Eng C; Neumann HP; Clin Cancer Res; 2009 Oct; 15(20):6378-85. PubMed ID: 19825962 [TBL] [Abstract][Full Text] [Related]
40. Screening of a Large Cohort of Asymptomatic SDHx Mutation Carriers in Routine Practice. Saie C; Buffet A; Abeillon J; Drui D; Leboulleux S; Bertherat J; Zenaty D; Storey C; Borson-Chazot F; Burnichon N; Vincent M; Favier J; Baudin E; Giraud S; Gimenez-Roqueplo AP; Amar L; Lussey-Lepoutre C J Clin Endocrinol Metab; 2021 Mar; 106(3):e1301-e1315. PubMed ID: 33247927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]